An 82-year-old woman with moderate neurocognitive disorder and newly diagnosed nonvalvular atrial fibrillation is being discharged from the inpatient medical service to a subacute rehabilitation facility. During her hospitalization, she experienced an episode of rapid ventricular response that necessitated the initiation of metoprolol and apixaban. Her previous home regimen of low-dose aspirin was intentionally discontinued. The discharging physician completes a comprehensive electronic discharge summary, transmits it securely to the receiving facility, and calls the facility's charge nurse, stating, 'The patient is stable for transfer; please note we started an anticoagulant and stopped her aspirin.' The nurse replies, 'Understood, we will expect her shortly.' Two days later, the patient is readmitted with a severe upper gastrointestinal hemorrhage. An investigation reveals that the facility's admitting provider generated the active orders by importing the patient's historical ambulatory medication list, resulting in the concomitant administration of apixaban and aspirin. Which of the following systemic interventions is most appropriate to prevent a recurrence of this specific type of error during inter-facility transitions?
- AStructuring the written discharge summary to include a dedicated, bolded section exclusively for discontinued home therapies
- BPostponing the patient's transfer until a legally authorized family surrogate is available to directly receive and verify the updated medication instructions
- Requiring a synchronous, closed-loop verification of the reconciled medication list with the receiving facility's prescribing providerAnswer
- DImplementing an automated pharmacy alert for potentially hazardous drug interactions within the discharging hospital's electronic health record
- EInitiating prophylactic acid-suppression therapy prior to discharge to mitigate the risk of hemorrhage from unintended dual antithrombotic use